Global Biologics Regulatory Affairs Outsourcing Market Size & Outlook
Global biologics regulatory affairs outsourcing market, 2018-2030 (US$M)
Related Markets
Global biologics regulatory affairs outsourcing market highlights
- The global biologics regulatory affairs outsourcing market generated a revenue of USD 2,216.3 million in 2024 and is expected to reach USD 3,690.8 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 9.1% by 2030.
- In terms of segment, regulatory writing & publishing accounted for a revenue of USD 617.6 million in 2024.
- Legal Representation is the most lucrative services segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 2,216.3 million |
| Market revenue in 2030 | USD 3,690.8 million |
| Growth rate | 9.1% (CAGR from 2025 to 2030) |
| Largest segment | Regulatory writing & publishing |
| Fastest growing segment | Legal Representation |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Regulatory Submissions, Regulatory Operations, Other Services, Regulatory Consulting |
Other key industry trends
- In terms of revenue, the North America accounted for 30.0% of the global biologics regulatory affairs outsourcing market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, India is the fastest growing regional market and is projected to reach USD 276.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biologics Regulatory Affairs Outsourcing Market Scope
Biologics Regulatory Affairs Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Dr. Regenold GmbH | View profile | 101-250 | Badenweiler, Baden-Wurttemberg, Germany, Europe | https://www.regenold.com/ |
| Biomapas | View profile | 101-250 | Kaunas, Kauno Apskritis, Lithuania, Europe | https://www.biomapas.com/ |
| Regulatory Pharma Net | View profile | 11-50 | Pisa, Toscana, Italy, Europe | https://www.regulatorypharmanet.com |
| PrimeVigilance Ltd. | View profile | 501-1000 | Guildford, Surrey, United Kingdom, Europe | http://www.primevigilance.com/ |
| Real Regulatory | View profile | 11-50 | Damastown, Dublin, Ireland, Europe | https://www.realregulatory.com |
| Freyr Solutions | View profile | 1001-5000 | Princeton, New Jersey, United States, North America | http://www.freyrsolutions.com/ |
| ZEINCRO Group | View profile | 101-250 | Sofia, Grad Sofiya, Bulgaria, Europe | https://www.zeincro.com/ |
| ProPharma Group | View profile | 251-500 | Overland Park, Kansas, United States, North America | http://www.propharmagroup.com/ |
| BlueReg Group | View profile | 101-250 | Paris, Ile-de-France, France, Europe | https://blue-reg.com |
| QVigilance | View profile | 11-50 | Hitchin, Hertford, United Kingdom, Europe | https://www.qvigilance.com |
| PharmaLex | View profile | 1001-5000 | Friedrichsdorf, Hessen, Germany, Europe | http://www.pharmalex.com/ |
| Promedica International | View profile | 11-50 | Costa Mesa, California, United States, North America | https://promedica-intl.com |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.parexel.com |
| Accell | View profile | 11-50 | Warrenton, Virginia, United States, North America | https://accellclinical.com/ |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Pharmexon | View profile | 11-50 | Prague, Hlavni mesto Praha, Czech Republic, Europe | https://pharmexon.com |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Criterium Inc. | View profile | 101-250 | Saratoga Springs, New York, United States, North America | http://criteriuminc.com |
| Genpact Ltd | View profile | 131000 | 22 Victoria Street, Canon's Court, Hamilton, Bermuda, HM 12 | https://www.genpact.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
Global biologics regulatory affairs outsourcing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biologics regulatory affairs outsourcing market will help companies and investors design strategic landscapes.
Regulatory writing & publishing was the largest segment with a revenue share of 27.87% in 2024. Horizon Databook has segmented the Global biologics regulatory affairs outsourcing market based on legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services, regulatory consulting covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Biologics Regulatory Affairs Outsourcing Services Outlook (Revenue, USD Million, 2018-2030)
- Legal Representation
- Regulatory Consulting
- Strategy & Development Planning
- Agent Services
- QA Consulting
- Others
- Regulatory Submissions
- Regulatory Writing & Publishing
- Product Registration & Clinical Trial Applications
- Regulatory Operations
- Other Services
- Global Biologics Regulatory Affairs Outsourcing Phase Outlook (Revenue, USD Million, 2018-2030)
- Clinical
- Phase I
- Phase III
- Phase IV
- Phase II
- Preclinical
- Clinical
- Global Biologics Regulatory Affairs Outsourcing Phase By Service Outlook (Revenue, USD Million, 2018-2030)
- Preclinical
- Regulatory Writing & Publishing
- Regulatory Consulting
- Regulatory Submissions
- Product Registration & Clinical Trial Applications
- Regulatory Operations
- Other Services
- Legal Representation
- Clinical
- Regulatory Writing & Publishing
- Regulatory Submissions
- Other Services
- Regulatory Consulting
- Regulatory Operations
- Legal Representation
- Product Registration & Clinical Trial Applications
- Preclinical
- Global Biologics Regulatory Affairs Outsourcing Modality Outlook (Revenue, USD Million, 2018-2030)
- Monoclonal Antibodies (mAbs)
- Vaccines
- Recombinant Proteins
- Cell & Gene Therapies
- Biosimilars
- Others
- Global Biologics Regulatory Affairs Outsourcing Phase by Modality Outlook (Revenue, USD Million, 2018-2030)
- Preclinical
- Vaccines
- Others
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins
- Cell & Gene Therapies
- Biosimilars
- Clinical
- Cell & Gene Therapies
- Biosimilars
- Monoclonal Antibodies (mAbs)
- Vaccines
- Recombinant Proteins
- Others
- Preclinical
- Global Biologics Regulatory Affairs Outsourcing Modality by Services Outlook (Revenue, USD Million, 2018-2030)
- Recombinant Proteins
- Regulatory Consulting
- Legal Representation
- Product Registration & Clinical Trial Applications
- Regulatory Submissions
- Other Services
- Regulatory Operations
- Regulatory Writing & Publishing
- Vaccines
- Regulatory Consulting
- Regulatory Writing & Publishing
- Product Registration & Clinical Trial Applications
- Legal Representation
- Regulatory Submissions
- Regulatory Operations
- Other Services
- Cell & Gene Therapies
- Regulatory Writing & Publishing
- Regulatory Operations
- Regulatory Consulting
- Legal Representation
- Regulatory Submissions
- Product Registration & Clinical Trial Applications
- Other Services
- Biosimilars
- Regulatory Consulting
- Regulatory Operations
- Regulatory Writing & Publishing
- Legal Representation
- Product Registration & Clinical Trial Applications
- Regulatory Submissions
- Other Services
- Others
- Legal Representation
- Regulatory Submissions
- Regulatory Operations
- Other Services
- Regulatory Consulting
- Regulatory Writing & Publishing
- Product Registration & Clinical Trial Applications
- Monoclonal Antibodies (mAbs)
- Regulatory Writing & Publishing
- Product Registration & Clinical Trial Applications
- Other Services
- Legal Representation
- Regulatory Submissions
- Regulatory Operations
- Regulatory Consulting
- Recombinant Proteins
Reasons to subscribe to Global biologics regulatory affairs outsourcing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global biologics regulatory affairs outsourcing market databook
-
Our clientele includes a mix of biologics regulatory affairs outsourcing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global biologics regulatory affairs outsourcing market , including forecasts for subscribers. This global databook contains high-level insights into Global biologics regulatory affairs outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global biologics regulatory affairs outsourcing market size, by regions, 2018-2030 (US$M)
Top 10 countries: Biologics regulatory affairs outsourcing market size, 2024 (US$M)
Global biologics regulatory affairs outsourcing market share, by services, 2024 & 2030 (%, US$M)
Biologics regulatory affairs outsourcing market: Opportunity assessment by country
Global biologics regulatory affairs outsourcing market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
